Endocrine Society GUIDELINES Bundle (free trial)

Primary Aldosteronism

Endocrine Society GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1140172

Contents of this Issue

Navigation

Page 2 of 13

3 Î ES recommends using the plasma aldosterone/renin ratio (ARR) to detect possible cases of PA in these patient groups. (1|⊕⊕⊕ ) Î Instead of proceeding directly to subtype classification, ES recommends that patients with a positive ARR undergo one or more confirmatory tests to definitively confirm or exclude the diagnosis (1|⊕⊕ ). However, in the setting of spontaneous hypokalemia, plasma renin below detection levels plus plasma aldosterone concentration (PAC) >20 ng/dL (550 pmol/L), ES suggets that there is no need for further confirmatory testing. (2|⊕ ) Î ES recommends that all patients with PA undergo adrenal computed tomography (CT) as in the initial study in subtype testing to exclude large masses that may represent adrenocortical carcinoma and to assist the interventional radiologist and surgeon where anatomically appropriate (Figure 1). (1|⊕⊕⊕ ) Î ES recommends that when surgical treatment is feasible and desired by the patient, an experienced radiologist should use adrenal venous sampling (AVS) to make the distinction between unilateral and bilateral adrenal disease (1|⊕⊕⊕ ). Younger patients (

Articles in this issue

Archives of this issue

view archives of Endocrine Society GUIDELINES Bundle (free trial) - Primary Aldosteronism